LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
10
 47.93 27.76 82 4421 0.0185 0.1596
MN20160318_Q01
E13
MCF 10A-H2B-mCherry Dasatinib
10
 47.93 27.76 638 4421 0.1443 0.5350
MN20160318_Q01
E13
MCF 10A-H2B-mCherry Dasatinib
10
 47.93 27.76 25 4421 0.0057 -0.0142
MN20160318_Q01
K20
MCF 10A-H2B-mCherry Dasatinib
10
 47.93 27.76 834 4421 0.1886 0.5922
MN20160318_Q01
K20
MCF 10A-H2B-mCherry Dasatinib
10
 49.63 27.76 91 4818 0.0189 0.1730
MN20160318_Q01
E13
MCF 10A-H2B-mCherry Dasatinib
10
 49.63 27.76 633 4818 0.1314 0.5225
MN20160318_Q01
E13
MCF 10A-H2B-mCherry Dasatinib
10
 49.63 27.76 17 4818 0.0035 -0.0638
MN20160318_Q01
K20
MCF 10A-H2B-mCherry Dasatinib
10
 49.63 27.76 828 4818 0.1719 0.5784
MN20160318_Q01
K20
MCF 10A-H2B-mCherry Dasatinib
10
 51.33 27.76 80 5117 0.0156 0.1510
MN20160318_Q01
E13
MCF 10A-H2B-mCherry Dasatinib
10
 51.33 27.76 643 5117 0.1257 0.5182
MN20160318_Q01
E13
MCF 10A-H2B-mCherry Dasatinib
10
 51.33 27.76 14 5117 0.0027 -0.0869
MN20160318_Q01
K20
MCF 10A-H2B-mCherry Dasatinib
10
 51.33 27.76 821 5117 0.1604 0.5684
MN20160318_Q01
K20
MCF 10A-H2B-mCherry Dasatinib
10
 53.04 27.76 90 5365 0.0168 0.1675
MN20160318_Q01
E13
MCF 10A-H2B-mCherry Dasatinib
10
 53.04 27.76 641 5365 0.1195 0.5119
MN20160318_Q01
E13
MCF 10A-H2B-mCherry Dasatinib
10
 53.04 27.76 15 5365 0.0028 -0.0778
MN20160318_Q01
K20
MCF 10A-H2B-mCherry Dasatinib
10
 53.04 27.76 803 5365 0.1497 0.5575
MN20160318_Q01
K20
MCF 10A-H2B-mCherry Dasatinib
10
 54.74 27.76 94 5606 0.0168 0.1727
MN20160318_Q01
E13
MCF 10A-H2B-mCherry Dasatinib
10
 54.74 27.76 634 5606 0.1131 0.5046
MN20160318_Q01
E13
MCF 10A-H2B-mCherry Dasatinib
10
 54.74 27.76 16 5606 0.0029 -0.0694
MN20160318_Q01
K20
MCF 10A-H2B-mCherry Dasatinib
10
 54.74 27.76 790 5606 0.1409 0.5485
MN20160318_Q01
K20
MCF 10A-H2B-mCherry Dasatinib
10
 56.45 27.76 87 5745 0.0151 0.1601
MN20160318_Q01
E13
MCF 10A-H2B-mCherry Dasatinib
10
 56.45 27.76 639 5745 0.1112 0.5033
MN20160318_Q01
E13
MCF 10A-H2B-mCherry Dasatinib
10
 56.45 27.76 13 5745 0.0023 -0.0939
MN20160318_Q01
K20
MCF 10A-H2B-mCherry Dasatinib
10
 56.45 27.76 790 5745 0.1375 0.5453
MN20160318_Q01
K20
MCF 10A-H2B-mCherry Dasatinib
10
 58.15 27.76 77 5906 0.0130 0.1410
MN20160318_Q01
E13